Incidence of Extrusion Following Type I Polypropylene Mesh “Kit” Repairs in the Correction of Pelvic Organ Prolapse

Table 4

Outcome variables for subjects with and without extrusion (AC or PC/A).

Variable^1	Baseline extrusion	Baseline nonextrusion	12-Month extrusion	12-Month nonextrusion	𝑃 value; (within group)^2	𝑃 value; (between groups)^3
Anterior compartment
POPQ	13/13	160/160	1/12	22/134	NA	NA
Anterior stage ≥ II	(100.0%)	(100.0%)	(8.3%)	(16.4%)	NA	0.692
Wong-Baker	1.8±2.8	1.6±2.0	1.3±2.4	0.5±1.1	0.781	0.685
Pain score^4	(𝑛=13)	(𝑛=160)	(𝑛=13)	(𝑛=151)	<.001	0.228
PFDI (symptoms)	44.6±24.6	35.7±26.2	16.7±20.4	14.4±20.4	0.024	0.243
Anterior POPDI	(𝑛=13)	(𝑛=160)	(𝑛=12)	(𝑛=135)	<.001	0.715
PFDI (symptoms)	130.2±58.2	101.4±55.6	40.0±43.3	32.3±39.4	<.001	0.075
UDI	(𝑛=13)	(𝑛=160)	(𝑛=12)	(𝑛=135)	<.001	0.523
PFIQ-7 (life impact)	31.1±37.0	16.6±24.0	12.7±26.9	3.6±12.4	0.008	0.186
POPIQ	(𝑛=13)	(𝑛=159)	(𝑛=12)	(𝑛=134)	<.001	0.267
PFIQ-7 (life impact)	42.9±33.4	32.8±27.4	19.8±26.6	8.1±15.9	0.061	0.211
UIQ	(𝑛=13)	(𝑛=160)	(𝑛=12)	(𝑛=134)	<.001	0.158
PISQ-12	31.1±7.7	32.0±7.1	34.1±8.7	37.5±5.9	0.151	0.693
(If sexually active)	(𝑛=10)	(𝑛=84)	(𝑛=8)	(𝑛=67)	<.001	0.149
Dyspareunia	5/10	36/83	5/8	20/67	1.000	0.745
(From PISQ-12, number 5)	(50.0%)	(43.4%)	(62.5%)	(29.9%)	0.491	0.108
Posterior compartment/Apex
POPQ	5/27	42/168	1/23	4/141	0.180	0.629
Apical stage ≥ II	(18.5%)	(25.0%)	(4.3%)	(2.8%)	<.001	0.535
POPQ	27/27	163/168	0/23	7/141	NA	1.000
Posterior stage ≥ II	(100.0%)	(97.0%)	(0.0%)	(5.0%)	<.001	0.595
Wong-Baker	1.1±1.9	2.0±2.5	0.7±0.9	0.5±1.0	0.367	0.094
Pain score^4	(𝑛=27)	(𝑛=167)	(𝑛=26)	(𝑛=162)	<.001	0.409
PFDI (symptoms)	48.5±38.3	47.2±36.0	27.2±35.4	19.5±27.9	0.001	0.863
POPDI posterior	(𝑛=27)	(𝑛=167)	(𝑛=23)	(𝑛=141)	<.001	0.242
PFDI (symptoms)	133.2±89.6	127.7±85.5	68.4±79.5	50.2±60.6	<.001	0.759
CRADI	(𝑛=27)	(𝑛=167)	(𝑛=23)	(𝑛=141)	<.001	0.204
PFIQ-7 (life impact)	21.7±27.5	19.1±25.8	2.9±8.5	4.6±14.2	<.001	0.637
POPIQ	(𝑛=27)	(𝑛=165)	(𝑛=23)	(𝑛=140)	<.001	0.432
PFIQ-7 (life impact)	18.3±26.6	22.9±27.2	10.1±18.3	4.8±13.9	0.093	0.415
CRAIQ	(𝑛=27)	(𝑛=165)	(𝑛=23)	(𝑛=140)	<.001	0.105
PISQ-12	33.4±6.4	32.3±7.4	38.6±4.9	36.9±6.2	0.046	0.592
(If sexually active)	(𝑛=15)	(𝑛=104)	(𝑛=15)	(𝑛=83)	<.001	0.323
Dyspareunia	7/15	43/105	3/15	28/83	0.083	0.782
(From PISQ-12, number 5)	(46.7%)	(41.0%)	(20.0%)	(33.7%)	0.450	0.376

¹Values are presented as 𝑁 (%) or Mean ± SD; NA: Not Available.
²𝑃 value paired comparison between baseline and 12 Months for the extrusion group and nonextrusion group.
³ 𝑃 value unpaired comparison between extrusion group and nonextrusion group for the baseline time-point and the 12-month time-point.
⁴Data at 3-month followup (Wong-Baker FACES pain scores were not collected at 12-month).